Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DIG | Ann: TGO: Bidder's Statement | 18/09/18 | 3 | 1.8K | |||
|
|||||||
DIG | Ann: Removal from Official List | 22/08/18 | 0 | 716 | |||
|
|||||||
DIG | Ann: Suspension from Official Quotation | 17/08/18 | 0 | 645 | |||
|
|||||||
DIG | News: DIG Trimantium Growthops Announces Compulsory Acquisition Of Shares In Asia Pacific Digital | 10/08/18 | 0 | 461 | |||
|
|||||||
DIG | Ann: TGO:Notice of comp acquisition following takeover bid | 10/08/18 | 0 | 656 | |||
|
|||||||
DIG | Ann: TGO:Clsoing of takeover offer | 08/08/18 | 0 | 683 | |||
|
|||||||
DIG | Ann: Change in substantial holding from TGO | 17:36 | 0 | 535 | |||
|
|||||||
DIG | Ann: TGO: Notice freeing takeover offer from defeating condition | 02/08/18 | 0 | 458 | |||
|
See All Discussions